Home/Filings/4/0001209191-23-043531
4//SEC Filing

Randolph Sophia 4

Accession 0001209191-23-043531

CIK 0001810182other

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 4:27 PM ET

Size

7.1 KB

Accession

0001209191-23-043531

Insider Transaction Report

Form 4
Period: 2023-07-25
Randolph Sophia
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-07-25+107,000107,000 total
    Exercise: $5.86Exp: 2033-07-24Common Stock (107,000 underlying)
  • Award

    Common Stock

    2023-07-25+34,000315,477 total
Footnotes (2)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
  • [F2]Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.

Issuer

ALX ONCOLOGY HOLDINGS INC

CIK 0001810182

Entity typeother

Related Parties

1
  • filerCIK 0001817127

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:27 PM ET
Size
7.1 KB